Armata Pharmaceuticals Inc (ARMP)
2.34
-0.02
(-0.85%)
USD |
NYAM |
Nov 04, 13:04
Armata Pharmaceuticals Enterprise Value: 170.38M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 170.38M |
| October 31, 2024 | 168.57M |
| October 30, 2024 | 168.20M |
| October 29, 2024 | 168.43M |
| October 28, 2024 | 169.02M |
| October 25, 2024 | 171.46M |
| October 24, 2024 | 171.46M |
| October 23, 2024 | 168.21M |
| October 22, 2024 | 171.82M |
| October 21, 2024 | 170.35M |
| October 18, 2024 | 170.55M |
| October 17, 2024 | 170.39M |
| October 16, 2024 | 171.82M |
| October 15, 2024 | 170.38M |
| October 14, 2024 | 170.38M |
| October 11, 2024 | 170.74M |
| October 10, 2024 | 170.01M |
| October 09, 2024 | 166.76M |
| October 08, 2024 | 168.57M |
| October 07, 2024 | 171.82M |
| October 04, 2024 | 171.82M |
| October 03, 2024 | 168.20M |
| October 02, 2024 | 168.93M |
| October 01, 2024 | 170.01M |
| September 30, 2024 | 170.74M |
| Date | Value |
|---|---|
| September 27, 2024 | 170.38M |
| September 26, 2024 | 167.84M |
| September 25, 2024 | 164.95M |
| September 24, 2024 | 164.95M |
| September 23, 2024 | 170.38M |
| September 20, 2024 | 171.82M |
| September 19, 2024 | 165.67M |
| September 18, 2024 | 160.97M |
| September 17, 2024 | 166.76M |
| September 16, 2024 | 163.86M |
| September 13, 2024 | 167.30M |
| September 12, 2024 | 164.59M |
| September 11, 2024 | 167.48M |
| September 10, 2024 | 171.82M |
| September 09, 2024 | 168.20M |
| September 06, 2024 | 169.29M |
| September 05, 2024 | 171.82M |
| September 04, 2024 | 174.54M |
| September 03, 2024 | 171.82M |
| August 30, 2024 | 173.63M |
| August 29, 2024 | 174.36M |
| August 28, 2024 | 171.82M |
| August 27, 2024 | 172.00M |
| August 26, 2024 | 174.36M |
| August 23, 2024 | 176.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.594M
Minimum
Dec 28 2022
235.09M
Maximum
Apr 01 2024
98.73M
Average
86.31M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 9.109M |
| Perspective Therapeutics Inc | 524.04M |
| Protalix BioTherapeutics Inc | 67.32M |
| Electromed Inc | 181.75M |
| Xtant Medical Holdings Inc | 102.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.986M |
| Total Expenses (Quarterly) | 11.91M |
| EPS Diluted (Quarterly) | -0.25 |
| Earnings Yield | -100.4% |
| Normalized Earnings Yield | -1800.91 |